| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchopulmonary Dysplasia | 17 | 2023 | 306 | 6.340 |
Why?
|
| Mesenchymal Stem Cells | 18 | 2022 | 1628 | 3.490 |
Why?
|
| Exosomes | 9 | 2019 | 413 | 3.190 |
Why?
|
| Heme Oxygenase-1 | 11 | 2021 | 381 | 2.620 |
Why?
|
| Hypertension, Pulmonary | 22 | 2023 | 1536 | 2.420 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 8 | 2021 | 495 | 1.860 |
Why?
|
| Muscle, Smooth, Vascular | 19 | 2019 | 1504 | 1.560 |
Why?
|
| Heme Oxygenase (Decyclizing) | 9 | 2009 | 171 | 1.500 |
Why?
|
| Infant, Premature, Diseases | 5 | 2023 | 706 | 1.440 |
Why?
|
| Lung Injury | 6 | 2022 | 436 | 1.390 |
Why?
|
| Stem Cell Transplantation | 7 | 2020 | 1620 | 1.320 |
Why?
|
| Hyperoxia | 5 | 2021 | 262 | 1.160 |
Why?
|
| Cord Blood Stem Cell Transplantation | 2 | 2021 | 314 | 1.070 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2022 | 582 | 1.030 |
Why?
|
| Pulmonary Fibrosis | 2 | 2019 | 529 | 0.970 |
Why?
|
| Carbon Monoxide | 8 | 2005 | 531 | 0.890 |
Why?
|
| Immunomodulation | 4 | 2021 | 541 | 0.870 |
Why?
|
| Persistent Fetal Circulation Syndrome | 6 | 2001 | 80 | 0.860 |
Why?
|
| Pre-Eclampsia | 2 | 2022 | 1200 | 0.820 |
Why?
|
| Premature Birth | 3 | 2023 | 1721 | 0.790 |
Why?
|
| Hypoxia-Ischemia, Brain | 2 | 2016 | 333 | 0.790 |
Why?
|
| Cell Hypoxia | 10 | 2017 | 675 | 0.780 |
Why?
|
| Lung | 19 | 2022 | 9852 | 0.740 |
Why?
|
| Nitric Oxide | 11 | 2020 | 2131 | 0.730 |
Why?
|
| Cell-Derived Microparticles | 2 | 2018 | 168 | 0.690 |
Why?
|
| Endothelium, Vascular | 18 | 2013 | 4455 | 0.680 |
Why?
|
| Bleomycin | 2 | 2019 | 501 | 0.670 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2022 | 341 | 0.650 |
Why?
|
| Pulmonary Alveoli | 5 | 2020 | 675 | 0.600 |
Why?
|
| Myeloid Cells | 1 | 2021 | 809 | 0.580 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2020 | 587 | 0.530 |
Why?
|
| Macrophages | 7 | 2021 | 5657 | 0.520 |
Why?
|
| Infant, Premature | 8 | 2023 | 2044 | 0.520 |
Why?
|
| Infant, Newborn | 24 | 2024 | 25618 | 0.510 |
Why?
|
| Intensive Care Units, Neonatal | 4 | 2024 | 780 | 0.510 |
Why?
|
| Oxygen | 7 | 2014 | 4187 | 0.510 |
Why?
|
| Inflammasomes | 1 | 2019 | 494 | 0.500 |
Why?
|
| Membrane Proteins | 5 | 2021 | 7879 | 0.480 |
Why?
|
| Endothelial Growth Factors | 7 | 1999 | 694 | 0.470 |
Why?
|
| Prenatal Care | 2 | 2020 | 1092 | 0.470 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2014 | 74 | 0.470 |
Why?
|
| Pulmonary Artery | 10 | 2019 | 1912 | 0.460 |
Why?
|
| Cell Communication | 4 | 2014 | 1621 | 0.460 |
Why?
|
| Lymphokines | 7 | 1999 | 949 | 0.450 |
Why?
|
| Animals, Newborn | 7 | 2021 | 2726 | 0.450 |
Why?
|
| Animals | 63 | 2023 | 168788 | 0.450 |
Why?
|
| Cyclic GMP | 7 | 2017 | 409 | 0.430 |
Why?
|
| Monocytes | 2 | 2019 | 2594 | 0.410 |
Why?
|
| Infant, Very Low Birth Weight | 4 | 2017 | 406 | 0.360 |
Why?
|
| Macrophages, Alveolar | 2 | 2019 | 407 | 0.360 |
Why?
|
| Mice | 26 | 2022 | 81178 | 0.360 |
Why?
|
| Lung Diseases | 4 | 2014 | 1885 | 0.350 |
Why?
|
| Fetal Growth Retardation | 2 | 2021 | 570 | 0.340 |
Why?
|
| Stem Cells | 4 | 2023 | 3567 | 0.340 |
Why?
|
| Neonatology | 1 | 2010 | 122 | 0.320 |
Why?
|
| Myocytes, Smooth Muscle | 4 | 2019 | 687 | 0.320 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 3646 | 0.320 |
Why?
|
| Macrophage Activation | 1 | 2011 | 558 | 0.310 |
Why?
|
| Bilirubin | 2 | 2009 | 425 | 0.310 |
Why?
|
| Hypoxia-Inducible Factor 1 | 5 | 2020 | 198 | 0.300 |
Why?
|
| Endothelin-1 | 7 | 2008 | 314 | 0.290 |
Why?
|
| Cells, Cultured | 24 | 2013 | 19227 | 0.290 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2018 | 582 | 0.280 |
Why?
|
| RNA, Messenger | 24 | 2019 | 13036 | 0.280 |
Why?
|
| Bone Marrow Cells | 2 | 2015 | 2513 | 0.280 |
Why?
|
| Telomerase | 2 | 2001 | 729 | 0.280 |
Why?
|
| Platelet-Derived Growth Factor | 7 | 1997 | 625 | 0.270 |
Why?
|
| Endothelial Cells | 3 | 2023 | 3478 | 0.260 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2005 | 1213 | 0.260 |
Why?
|
| Acidosis | 2 | 2019 | 272 | 0.260 |
Why?
|
| Pregnancy | 9 | 2023 | 29142 | 0.260 |
Why?
|
| Disease Models, Animal | 13 | 2023 | 18027 | 0.250 |
Why?
|
| Endothelins | 6 | 1995 | 138 | 0.250 |
Why?
|
| Cell Proliferation | 5 | 2014 | 10480 | 0.240 |
Why?
|
| Gene Expression Regulation | 10 | 2021 | 12075 | 0.240 |
Why?
|
| Rats | 19 | 2021 | 24273 | 0.230 |
Why?
|
| Humans | 64 | 2024 | 744220 | 0.230 |
Why?
|
| Umbilical Cord | 3 | 2021 | 180 | 0.220 |
Why?
|
| NF-kappa B | 2 | 2019 | 2501 | 0.220 |
Why?
|
| Signal Transduction | 7 | 2021 | 23404 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 480 | 0.210 |
Why?
|
| Gene Expression | 8 | 2001 | 7799 | 0.210 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 489 | 0.210 |
Why?
|
| Growth Substances | 2 | 1995 | 783 | 0.210 |
Why?
|
| Carbon Dioxide | 3 | 2012 | 1147 | 0.210 |
Why?
|
| Ammonium Chloride | 2 | 2019 | 74 | 0.210 |
Why?
|
| Vascular Endothelial Growth Factors | 7 | 1999 | 772 | 0.200 |
Why?
|
| Syndecan-2 | 1 | 2021 | 23 | 0.200 |
Why?
|
| Carrier Proteins | 4 | 2006 | 5021 | 0.200 |
Why?
|
| Peptide PHI | 1 | 2020 | 4 | 0.200 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2006 | 838 | 0.190 |
Why?
|
| Pneumonia | 3 | 2012 | 2134 | 0.190 |
Why?
|
| Chorioamnionitis | 1 | 2021 | 155 | 0.190 |
Why?
|
| Body Fluids | 1 | 2022 | 319 | 0.180 |
Why?
|
| Pregnancy, Animal | 1 | 2020 | 134 | 0.180 |
Why?
|
| Trophoblasts | 1 | 2021 | 215 | 0.180 |
Why?
|
| Inflammation | 6 | 2021 | 10634 | 0.180 |
Why?
|
| Adult Stem Cells | 2 | 2012 | 216 | 0.180 |
Why?
|
| Transcription Factors | 7 | 2006 | 12207 | 0.180 |
Why?
|
| Chemokines | 1 | 2004 | 969 | 0.180 |
Why?
|
| Regenerative Medicine | 2 | 2014 | 307 | 0.180 |
Why?
|
| Amniotic Fluid | 1 | 2022 | 370 | 0.180 |
Why?
|
| Acetazolamide | 1 | 2019 | 100 | 0.170 |
Why?
|
| Mice, Transgenic | 6 | 2012 | 9735 | 0.170 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2019 | 95 | 0.170 |
Why?
|
| Carbonic Anhydrases | 1 | 2019 | 115 | 0.170 |
Why?
|
| Blood Vessels | 2 | 2002 | 1126 | 0.170 |
Why?
|
| Caspase 1 | 1 | 2019 | 224 | 0.170 |
Why?
|
| Lipopolysaccharides | 3 | 2021 | 2216 | 0.160 |
Why?
|
| Transcription, Genetic | 11 | 2006 | 7723 | 0.160 |
Why?
|
| Interleukin-18 | 1 | 2019 | 249 | 0.160 |
Why?
|
| Aftercare | 1 | 2024 | 866 | 0.150 |
Why?
|
| Acute Lung Injury | 1 | 2021 | 380 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2021 | 8302 | 0.150 |
Why?
|
| Amino Acid Oxidoreductases | 2 | 1994 | 151 | 0.150 |
Why?
|
| DNA-Binding Proteins | 8 | 2006 | 9647 | 0.150 |
Why?
|
| Phosphoproteins | 1 | 2006 | 2440 | 0.150 |
Why?
|
| Respiratory Function Tests | 2 | 2020 | 1618 | 0.150 |
Why?
|
| Surface-Active Agents | 1 | 2017 | 159 | 0.150 |
Why?
|
| Random Allocation | 2 | 2020 | 2427 | 0.150 |
Why?
|
| Uterus | 1 | 2021 | 710 | 0.140 |
Why?
|
| Paracrine Communication | 2 | 2021 | 276 | 0.140 |
Why?
|
| Infant | 6 | 2024 | 35129 | 0.140 |
Why?
|
| Thymus Gland | 1 | 2021 | 1267 | 0.140 |
Why?
|
| Complex Mixtures | 1 | 2015 | 28 | 0.140 |
Why?
|
| Fetus | 2 | 2022 | 1880 | 0.130 |
Why?
|
| Aspergillus | 1 | 2015 | 85 | 0.130 |
Why?
|
| Hyphae | 1 | 2015 | 56 | 0.130 |
Why?
|
| Transcriptional Activation | 3 | 2011 | 1782 | 0.130 |
Why?
|
| Phenotype | 4 | 2021 | 16365 | 0.130 |
Why?
|
| PPAR gamma | 1 | 2018 | 493 | 0.130 |
Why?
|
| Cell Division | 6 | 2011 | 4567 | 0.130 |
Why?
|
| Platelet Activation | 1 | 1998 | 673 | 0.130 |
Why?
|
| Drug Delivery Systems | 2 | 2017 | 2218 | 0.120 |
Why?
|
| Stromal Cells | 2 | 2011 | 1355 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2004 | 2938 | 0.120 |
Why?
|
| Culture Media, Conditioned | 2 | 2012 | 534 | 0.120 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 972 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 21824 | 0.120 |
Why?
|
| Cattle | 8 | 1999 | 3922 | 0.120 |
Why?
|
| Vasodilation | 1 | 2017 | 944 | 0.110 |
Why?
|
| Transforming Growth Factors | 2 | 1990 | 76 | 0.110 |
Why?
|
| Vasoconstriction | 3 | 2012 | 597 | 0.110 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2013 | 109 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 2 | 1998 | 1341 | 0.110 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 1640 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 7 | 1999 | 3506 | 0.110 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2000 | 1356 | 0.110 |
Why?
|
| Stroke Volume | 1 | 2005 | 5008 | 0.110 |
Why?
|
| Acidosis, Respiratory | 1 | 2012 | 37 | 0.100 |
Why?
|
| Attitude to Health | 1 | 2001 | 2053 | 0.100 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2013 | 314 | 0.100 |
Why?
|
| Mice, Knockout | 2 | 2021 | 14556 | 0.100 |
Why?
|
| Hemosiderosis | 1 | 2012 | 71 | 0.100 |
Why?
|
| Female | 16 | 2023 | 380197 | 0.100 |
Why?
|
| Lactoferrin | 1 | 2012 | 97 | 0.100 |
Why?
|
| Administration, Inhalation | 3 | 2000 | 1104 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 2 | 2019 | 6386 | 0.100 |
Why?
|
| Parents | 2 | 2024 | 3407 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 1999 | 627 | 0.100 |
Why?
|
| Anaerobiosis | 1 | 2011 | 140 | 0.100 |
Why?
|
| Airway Remodeling | 1 | 2012 | 132 | 0.090 |
Why?
|
| Immunohistochemistry | 3 | 2020 | 11368 | 0.090 |
Why?
|
| Oxygen Consumption | 1 | 1997 | 1869 | 0.090 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2021 | 767 | 0.090 |
Why?
|
| Fatty Acids | 1 | 2018 | 1808 | 0.090 |
Why?
|
| Umbilical Veins | 4 | 1995 | 433 | 0.090 |
Why?
|
| Treatment Outcome | 4 | 2021 | 63119 | 0.090 |
Why?
|
| Nitric Oxide Synthase | 4 | 1995 | 916 | 0.080 |
Why?
|
| Ferritins | 1 | 2012 | 590 | 0.080 |
Why?
|
| Pulmonary Edema | 1 | 2012 | 414 | 0.080 |
Why?
|
| Kartagener Syndrome | 1 | 2008 | 32 | 0.080 |
Why?
|
| Endotoxins | 2 | 2021 | 527 | 0.080 |
Why?
|
| Encephalitis | 1 | 2012 | 423 | 0.080 |
Why?
|
| Kinetics | 5 | 2005 | 6474 | 0.080 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 874 | 0.080 |
Why?
|
| Adenylate Kinase | 1 | 2008 | 100 | 0.080 |
Why?
|
| Health Status | 1 | 2001 | 4034 | 0.080 |
Why?
|
| Vasodilator Agents | 3 | 2020 | 977 | 0.080 |
Why?
|
| Pulmonary Circulation | 2 | 2020 | 739 | 0.080 |
Why?
|
| Aorta | 4 | 2005 | 2061 | 0.080 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 2020 | 367 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2018 | 2925 | 0.070 |
Why?
|
| Sepsis | 1 | 2021 | 2593 | 0.070 |
Why?
|
| Culture Media | 2 | 2005 | 908 | 0.070 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2006 | 47 | 0.070 |
Why?
|
| Fetal Diseases | 1 | 2012 | 903 | 0.070 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2010 | 501 | 0.070 |
Why?
|
| Frameshift Mutation | 1 | 2008 | 399 | 0.070 |
Why?
|
| Biliverdine | 1 | 2005 | 29 | 0.070 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2006 | 68 | 0.070 |
Why?
|
| Fibroblast Growth Factors | 2 | 1989 | 879 | 0.070 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2006 | 170 | 0.070 |
Why?
|
| Interleukin-10 | 1 | 2011 | 1200 | 0.070 |
Why?
|
| Infant Mortality | 1 | 2010 | 754 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2008 | 611 | 0.070 |
Why?
|
| Pulmonary Surfactants | 3 | 2013 | 162 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2009 | 6367 | 0.060 |
Why?
|
| Base Sequence | 7 | 2008 | 12801 | 0.060 |
Why?
|
| Muscle Tonus | 1 | 2005 | 81 | 0.060 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2013 | 808 | 0.060 |
Why?
|
| Fibroblasts | 2 | 2012 | 4156 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2012 | 1404 | 0.060 |
Why?
|
| Chemokine CXCL2 | 1 | 2004 | 111 | 0.060 |
Why?
|
| Heart Failure | 3 | 2020 | 10905 | 0.060 |
Why?
|
| Cell Death | 1 | 2009 | 1708 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2008 | 1726 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2016 | 3591 | 0.060 |
Why?
|
| Iron | 1 | 2012 | 1774 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 10182 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2020 | 5180 | 0.060 |
Why?
|
| Blotting, Northern | 2 | 1998 | 1581 | 0.060 |
Why?
|
| Enzyme Induction | 2 | 2001 | 475 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 1827 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2005 | 594 | 0.050 |
Why?
|
| Patient Admission | 1 | 2010 | 1380 | 0.050 |
Why?
|
| Autistic Disorder | 1 | 2012 | 1185 | 0.050 |
Why?
|
| Transgenes | 2 | 2008 | 1009 | 0.050 |
Why?
|
| NAD | 1 | 2006 | 594 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14726 | 0.050 |
Why?
|
| Pediatrics | 1 | 2017 | 3469 | 0.050 |
Why?
|
| Infant Care | 1 | 2024 | 183 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 1677 | 0.050 |
Why?
|
| Cytokines | 2 | 2009 | 7326 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 7908 | 0.050 |
Why?
|
| Research Design | 1 | 2017 | 5987 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 1 | 2009 | 2763 | 0.050 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2001 | 70 | 0.050 |
Why?
|
| Amino Acids, Dicarboxylic | 1 | 2020 | 25 | 0.050 |
Why?
|
| Male | 16 | 2019 | 350027 | 0.050 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 2 | 1997 | 142 | 0.050 |
Why?
|
| Transcription Factor DP1 | 2 | 1997 | 141 | 0.050 |
Why?
|
| Disease Progression | 1 | 2017 | 13280 | 0.050 |
Why?
|
| Prostaglandins I | 1 | 2020 | 13 | 0.050 |
Why?
|
| Pericytes | 1 | 2023 | 291 | 0.050 |
Why?
|
| Myocytes, Cardiac | 1 | 2009 | 1637 | 0.050 |
Why?
|
| Sensation Disorders | 1 | 2001 | 156 | 0.050 |
Why?
|
| E2F1 Transcription Factor | 2 | 1997 | 190 | 0.050 |
Why?
|
| E2F Transcription Factors | 2 | 1997 | 277 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 2557 | 0.040 |
Why?
|
| Nuclear Proteins | 4 | 1999 | 5853 | 0.040 |
Why?
|
| Injections, Intralesional | 1 | 2020 | 276 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2020 | 290 | 0.040 |
Why?
|
| Blood Circulation | 1 | 2000 | 251 | 0.040 |
Why?
|
| Molecular Sequence Data | 6 | 2008 | 18116 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2001 | 2969 | 0.040 |
Why?
|
| Hypotension | 1 | 2005 | 880 | 0.040 |
Why?
|
| NADPH Dehydrogenase | 2 | 1995 | 45 | 0.040 |
Why?
|
| Contractile Proteins | 1 | 2019 | 246 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2021 | 645 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2001 | 3800 | 0.040 |
Why?
|
| Adenosine Diphosphate | 1 | 1998 | 425 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2013 | 3311 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2024 | 1147 | 0.040 |
Why?
|
| Hemodynamics | 2 | 2018 | 4199 | 0.040 |
Why?
|
| Guanylate Cyclase | 1 | 1998 | 201 | 0.040 |
Why?
|
| Protein Precursors | 2 | 1992 | 1154 | 0.040 |
Why?
|
| Vascular Resistance | 1 | 2020 | 937 | 0.040 |
Why?
|
| High-Frequency Ventilation | 1 | 1997 | 87 | 0.040 |
Why?
|
| Receptors, Growth Factor | 1 | 1998 | 334 | 0.040 |
Why?
|
| Apoptosis | 2 | 2013 | 9728 | 0.040 |
Why?
|
| Cell Movement | 1 | 2009 | 5216 | 0.040 |
Why?
|
| Respiratory Mucosa | 2 | 2012 | 427 | 0.040 |
Why?
|
| Asthma | 1 | 2015 | 6011 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2001 | 1539 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2001 | 643 | 0.040 |
Why?
|
| Acute Disease | 2 | 2005 | 7148 | 0.040 |
Why?
|
| Consensus Sequence | 1 | 1997 | 377 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2012 | 3747 | 0.040 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2020 | 349 | 0.030 |
Why?
|
| Nitroarginine | 1 | 1995 | 66 | 0.030 |
Why?
|
| P-Selectin | 1 | 1998 | 600 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2021 | 1538 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 1012 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2001 | 3701 | 0.030 |
Why?
|
| Carboxyhemoglobin | 1 | 1995 | 81 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 2025 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 1997 | 3461 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2021 | 1538 | 0.030 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 1998 | 664 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2019 | 1731 | 0.030 |
Why?
|
| Genotype | 1 | 2009 | 12956 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9438 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 1998 | 798 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2008 | 9147 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 1998 | 1950 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 1372 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 1998 | 5974 | 0.030 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2013 | 43 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2001 | 6172 | 0.030 |
Why?
|
| Arterioles | 1 | 1994 | 254 | 0.030 |
Why?
|
| Time Factors | 5 | 2001 | 40063 | 0.030 |
Why?
|
| RNA | 2 | 2001 | 2749 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 1994 | 251 | 0.030 |
Why?
|
| DNA Primers | 2 | 1995 | 2892 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1995 | 599 | 0.030 |
Why?
|
| Protein Biosynthesis | 2 | 1994 | 2126 | 0.030 |
Why?
|
| Interleukin-1 | 2 | 1994 | 1263 | 0.030 |
Why?
|
| Reference Values | 1 | 2020 | 4982 | 0.030 |
Why?
|
| Gestational Age | 1 | 2022 | 3493 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2001 | 1456 | 0.030 |
Why?
|
| Placenta | 1 | 2021 | 1697 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 2187 | 0.030 |
Why?
|
| Monocrotaline | 1 | 2012 | 26 | 0.030 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2012 | 30 | 0.030 |
Why?
|
| Bronchioles | 1 | 2012 | 25 | 0.030 |
Why?
|
| Uteroglobin | 1 | 2012 | 58 | 0.030 |
Why?
|
| Cholinergic Agonists | 1 | 2012 | 74 | 0.030 |
Why?
|
| Arginine | 1 | 1995 | 944 | 0.030 |
Why?
|
| Proteome | 1 | 2022 | 1798 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 1995 | 1341 | 0.030 |
Why?
|
| Nitroprusside | 1 | 2012 | 275 | 0.030 |
Why?
|
| Organ Size | 2 | 2012 | 2252 | 0.030 |
Why?
|
| Multigene Family | 1 | 1995 | 1102 | 0.020 |
Why?
|
| Phenylephrine | 1 | 2012 | 301 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2024 | 3313 | 0.020 |
Why?
|
| Cell Survival | 1 | 2001 | 5881 | 0.020 |
Why?
|
| Cell Line | 2 | 2004 | 15999 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2001 | 1623 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 1998 | 1660 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2001 | 8437 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2012 | 569 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 3617 | 0.020 |
Why?
|
| Pulmonary Medicine | 1 | 2012 | 213 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1999 | 1888 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2012 | 621 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2013 | 748 | 0.020 |
Why?
|
| Trans-Activators | 1 | 1999 | 2924 | 0.020 |
Why?
|
| Hemoglobins | 1 | 1995 | 1533 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 1992 | 709 | 0.020 |
Why?
|
| Anemia, Sickle Cell | 1 | 1997 | 1018 | 0.020 |
Why?
|
| Neutrophils | 1 | 2021 | 3717 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 2191 | 0.020 |
Why?
|
| Iloprost | 1 | 2008 | 29 | 0.020 |
Why?
|
| Proteomics | 1 | 2022 | 3637 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2013 | 764 | 0.020 |
Why?
|
| Receptor, Endothelin A | 1 | 2008 | 58 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2012 | 643 | 0.020 |
Why?
|
| Sarcoma Viruses, Murine | 1 | 1988 | 66 | 0.020 |
Why?
|
| Traction | 1 | 2008 | 106 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 1999 | 2072 | 0.020 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2008 | 110 | 0.020 |
Why?
|
| Child | 3 | 2024 | 77679 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2012 | 1676 | 0.020 |
Why?
|
| Cell Count | 1 | 2012 | 1854 | 0.020 |
Why?
|
| Models, Biological | 1 | 2004 | 9582 | 0.020 |
Why?
|
| Echocardiography | 1 | 2020 | 5103 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 1375 | 0.020 |
Why?
|
| Oncogenes | 1 | 1993 | 1265 | 0.020 |
Why?
|
| Gels | 1 | 2008 | 427 | 0.020 |
Why?
|
| Actins | 1 | 1994 | 2121 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1994 | 1948 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2008 | 719 | 0.020 |
Why?
|
| Pulmonary Emphysema | 1 | 2012 | 672 | 0.020 |
Why?
|
| Cell Transformation, Viral | 1 | 1988 | 565 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 1994 | 2008 | 0.020 |
Why?
|
| Proteolipids | 1 | 1986 | 117 | 0.020 |
Why?
|
| Models, Animal | 1 | 2012 | 2171 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2008 | 600 | 0.020 |
Why?
|
| Cell Cycle | 2 | 1995 | 2967 | 0.020 |
Why?
|
| DNA | 2 | 1997 | 7303 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2001 | 5529 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 3533 | 0.020 |
Why?
|
| Heparin | 1 | 1992 | 1637 | 0.020 |
Why?
|
| Cilia | 1 | 2008 | 466 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1866 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2012 | 8551 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2008 | 2335 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2013 | 4217 | 0.010 |
Why?
|
| Mitosis | 1 | 1989 | 1208 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 2019 | 11478 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2001 | 5319 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 2008 | 1241 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2012 | 2504 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2012 | 2047 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1994 | 4553 | 0.010 |
Why?
|
| Hospitalization | 1 | 2001 | 10262 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 2008 | 13817 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1992 | 4419 | 0.010 |
Why?
|
| Prognosis | 1 | 2000 | 29050 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 4188 | 0.010 |
Why?
|
| Peptides | 1 | 2012 | 4407 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2001 | 39045 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2012 | 3820 | 0.010 |
Why?
|
| Collagen | 1 | 2008 | 2689 | 0.010 |
Why?
|
| Deferoxamine | 1 | 1999 | 151 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2013 | 4289 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2001 | 40992 | 0.010 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 3047 | 0.010 |
Why?
|
| Ventricular Pressure | 1 | 1999 | 199 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 1999 | 11728 | 0.010 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 1999 | 209 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 1999 | 520 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 20123 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2000 | 53280 | 0.010 |
Why?
|
| E2F5 Transcription Factor | 1 | 1995 | 4 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 1999 | 912 | 0.010 |
Why?
|
| E2F4 Transcription Factor | 1 | 1995 | 36 | 0.010 |
Why?
|
| E2F3 Transcription Factor | 1 | 1995 | 40 | 0.010 |
Why?
|
| E2F2 Transcription Factor | 1 | 1995 | 38 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1999 | 1526 | 0.010 |
Why?
|
| Mutation | 1 | 1999 | 29784 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1994 | 317 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1994 | 347 | 0.010 |
Why?
|
| Nitrites | 1 | 1994 | 160 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 1999 | 1114 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 35423 | 0.010 |
Why?
|
| Cyclins | 1 | 1995 | 603 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1995 | 1100 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1992 | 821 | 0.010 |
Why?
|
| Retinoblastoma Protein | 1 | 1995 | 704 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1999 | 3772 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 708 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 2839 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1995 | 2256 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1995 | 2007 | 0.010 |
Why?
|
| Adult | 2 | 2001 | 214035 | 0.010 |
Why?
|
| Gene Library | 1 | 1992 | 1076 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 1995 | 1159 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 1999 | 5867 | 0.000 |
Why?
|
| Protein Binding | 1 | 1999 | 9392 | 0.000 |
Why?
|
| Precipitin Tests | 1 | 1988 | 829 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1999 | 5096 | 0.000 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 1 | 1986 | 19 | 0.000 |
Why?
|
| Cloning, Molecular | 1 | 1992 | 4321 | 0.000 |
Why?
|
| United States | 1 | 2013 | 69867 | 0.000 |
Why?
|
| Risk Factors | 1 | 2012 | 72280 | 0.000 |
Why?
|
| Capillaries | 1 | 1988 | 774 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1988 | 2645 | 0.000 |
Why?
|
| Interferon-gamma | 1 | 1992 | 3203 | 0.000 |
Why?
|
| Methionine | 1 | 1986 | 590 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1986 | 1801 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1992 | 6612 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1994 | 10949 | 0.000 |
Why?
|
| Age Factors | 1 | 1995 | 18367 | 0.000 |
Why?
|